ArticleScientific reports2025
Integrated bioinformatics and experimental validation identify lysosome and immune infiltration-related genes as therapeutic targets in late-onset major depressive disorder.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lysosomal Dysfunction Is Associated With Intervertebral Disc Degeneration: Multiomics and Machine Learning Identify Molecular Subtypes and Hub Genes.The journal of gene medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study leverages bioinformatics to identify differential genes linked to lysosomal alterations in late-onset major depressivedisorder (LOD) patients and explores potential therapeutic drugs. We analyzed differential genes in the GSE76826 dataset usingWGCNA to identify modules associated with LOD. After intersecting with lysosomal genes, we utilized ROC and Lasso regression toassess diagnostic significance. Pathway enrichment analysis was conducted on key modules, followed by CIBESORT, MCPcounter,and quanTIseq to analyze immune infiltration in LOD patients. The changes in the expression of selected genes were confirmedthrough a chronic unpredictable mild stress model. The ITCM database predicted small molecule drugs targeting lysosome-relatedgenes. We selected ANK3, BIN1, CKAP4, GPRASP1, MYO7A, and RAB20 from the Green module, which showed diagnostic value.GO biological processes revealed a link to T cell differentiation and its regulation. Immune infiltration analysis indicated a relationshipbetween LOD patients and CD8 + T cells and neutrophils, with BIN1 positively correlating with CD8 + T cells. RT-qPCR verification inanimal models confirmed our bioinformatics findings. The ITCM database suggested that 17-beta-estradiol and nickel compoundscould be potential treatments for LOD. LOD's etiology involves multiple genes and pathways, with CD8 + T cells and Neutrophils cellspotentially advancing the disorder. 17-beta-estradiol and nickel may offer targeted therapeutic options for LOD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.